不可分类骨髓增殖性肿瘤的临床病理特征:英国大型三级转诊中心回顾性分析
常见表现为乳酸脱氢酶升高、血小板增多及骨髓活检巨核细胞簇集/多形性,血栓发生率21%。
要点
- MPN-U患者血栓发生率21%,需保持警惕。
- 低血小板(<500×10^9/L)和白细胞增多(≥12×10^9/L)提示预后更差。
核心结论
- MPN-U表型异质但常见乳酸脱氢酶升高、血小板增多和巨核细胞簇集/多形性。
- 需要建立MPN-U专用预后评分体系。
研究设计与样本
- 回顾性分析英国大型三级转诊中心注册队列中1512例MPN患者,纳入82例MPN-U。
主要发现
- 常见表现包括乳酸脱氢酶升高、血小板增多和骨髓活检巨核细胞簇集/多形性。
- 血栓发生率为21%。
- 低血小板计数(<500×10^9/L)和白细胞增多(≥12×10^9/L)者无事件生存期显著缩短。
临床怎么用
- 对MPN-U患者应警惕血栓风险。
- 低血小板计数(<500×10^9/L)和白细胞增多(≥12×10^9/L)可用于识别预后较差患者。
局限性
- 回顾性分析,样本量较小(82例MPN-U),来自单中心注册队列。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myeloproliferative neoplasm-unclassifiable (MPN-U) presents an MPN-type phenotype that fails to meet diagnostic criteria for other MPN variants. Variability in the clinicopathological phenotypes presents many challenges. Amongst a registry cohort of 1512 patients with MPN, 82 with MPN-U were included, with a median (range) age of 49·7 (13-79) years. Albeit heterogeneous, common presentation features included raised lactate dehydrogenase, thrombocytosis and clustered/pleomorphic megakaryocytes on trephine biopsy. Thrombosis was common (21%), necessitating vigilance. The median event-free survival was 11·25 years (95% confidence interval 9·3-not reached), significantly shortened in cases with lower platelet counts (<500 × 109 /l) and a leucocytosis (≥12 × 109 /l) at presentation. Generation of potential MPN-U prognostic scores is required.
引用
- Deschamps P, Moonim M, Radia D, et al. Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre. Br J Haematol. 2021. PMID: 33751548. doi:10.1111/bjh.17375
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。